Skip to main content

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 27 05 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Havila Kystruten AS: Notice of Annual General Meeting June 11th, 2026.

The Board of Directors of Havila Kystruten AS hereby gives notice of the Annual General Meeting. The meeting will take place on Thursday, June 11th, 2026 at 10:00 CEST. The Annual General Meeting will be held as a digital meeting with electronic voting via Lumi platform. It is also possible to cast votes or give proxy authorizations in advance. Notice of the Annual General Meeting together with all relevant documents is available at www.havilavoyages.com/nb/ir (http://www.havilavoyages.com/nb/ir). Further information can be found in the notice of the Annual General Meeting which is attached hereto. Contacts: Chief Executive Officer: Bent Martini, +47 905 99 650 Chief Financial Officer: Aleksander Røynesdal, +47 413 18 114  AttachmentHAVI_KYSTRUTEN_GF_11_06_2026

Continue reading

Virtune informs about a technical update regarding the review date for the Virtune Stablecoin Index (STABLEI) in the index methodology provided by the index provider MarketVector

This information is such that the issuer is obliged to make public pursuant to Chapter 15, Section 8 of the Swedish Securities Market Act (2007:528). Stockholm, 28 May 2026 – Virtune announces that the issuer’s index provider, MarketVector Indexes™ (“MarketVector”), will carry out a change to the review date for the Virtune Stablecoin Index (STABLEI). The review date will be changed from four to seven business days prior to the first business day of the month. The change will be effective from the June review. This adjustment applies only to the review schedule of the Virtune Stablecoin Index (STABLEI) and does not affect the value of the product, its structure, trading, or investors. No action is required from investors. The amended index guide will be available for download no later than 2026-05-29: https://www.marketvector.com/indexes/digital-assets/virtune-stablecoin. Press...

Continue reading

LIFT Files NI 43-101 Technical Report on the Adina-Galinée Lithium Project, Quebec, Canada

VANCOUVER, British Columbia, May 28, 2026 (GLOBE NEWSWIRE) — Li-FT Power Ltd. (“LIFT” or the “Company”) (TSXV: LIFT) (ASX: LFT) (OTCQX: LIFFF) (Frankfurt: WS0) is pleased to announce it has filed on SEDAR+ a technical report (the “Technical Report”), prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”), titled ” Adina-Galinée Lithium Project Quebec, Canada,” The Technical Report has an effective date of May 7, 2026, and a report date of May 26, 2026. The primary purpose of the Technical Report was to conform the Adina-Galinée Project’s existing Mineral Resource Estimate — previously prepared under the Australasian JORC Code — to Canadian NI 43-101 standards. The Technical Report contains no new material to that included in Annexure C of the Prospectus...

Continue reading

SCOR successfully sponsors a new catastrophe bond, Atlas Capital DAC Series 2026-1

Press release28 May 2026 – N° 11 SCOR successfully sponsors a new catastrophe bond, Atlas Capital DAC Series 2026-1 SCOR has successfully sponsored a new catastrophe bond (“cat bond”), Atlas Capital DAC Series 2026-1, which will provide the Group with multi-year risk transfer capacity of USD 75 million to protect itself against named storms in the US and the Caribbean, earthquakes in the US and Canada, and European windstorms. The risk period for Atlas Capital DAC Series 2026-1 will run from 1 June 2026 to 31 May 2029. The transaction has received the approval of the Irish regulatory authorities. The cat bond offering integrates ESG-related considerations to support investors’ due diligence. The cat bond was priced on 20 May 2026 with an interest spread of 6.00% and was issued on 27 May 2026. Atlas Capital DAC Series 2026-1...

Continue reading

Analyst report highlights Q1 2026 bookings of c.€2.5 million, implying an annualised run-rate above €10 million

Bilbao, May 28, 2026.- Virtualware (EPA: ALVIR), a leading expert in enterprise XR and industrial simulation software, listed on Euronext Growth Paris, has received an initiation of coverage report published on May 20 by LKS Next research team. The report estimates a fair value range of €5.9–€6.5 per share, with a central value of c.€6.3, based on a combined DCF and peer-multiple approach. At the date of the report, the shares last traded at €5.95. The report highlights that Q1 2026 bookings already reached c.€2.5 million, with c.29% generated in the US, implying an annualised booking run-rate above €10 million, ahead of the record €8 million achieved in full-year 2025.Revenue is projected to grow from €4.3 million in 2025 to €5.7 million in 2026 and €8.4 million by 2028. EBITDA margins are expected to expand from 14.5% in 2025 to 25.6%...

Continue reading

Pulsar Helium Welcomes Landmark Minnesota Helium Regulation as Topaz Advances Toward First Production Amid Global Helium Shortage

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO. 596/2014 ON MARKET ABUSE, AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AND REGULATION (EU) NO. 596/2014 ON MARKET ABUSE. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN...

Continue reading

New late-breaking data reinforces IQIRVO®’s impact on ALP, fatigue and pruritus in PBC

 IQIRVO® data expands scientific evidence in fatigue, showing clinically meaningful improvements in patients with moderate-to-severe fatigue at baseline In the first real-world analysis in patients with PBC and an ALP 1-1.67 x ULN, IQIRVO demonstrated a significant ALP reduction, with 59% of patients achieving ALP normalization at 6 months Interim analysis from the ELFINITY Phase IV study highlights real-world effectiveness and tolerability of IQIRVO in both biochemical and symptom control, including fatigue and pruritusPARIS, FRANCE, 28 MAY 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced the presentation of new late-breaking results from the ELATIVE® Phase III trial and two real-world studies at the European Association for the Study of the Liver (EASL) congress. Together, these data further strengthen the growing body...

Continue reading

Azerion publishes Interim Unaudited Financial Results Q1 2026

 Bottom line focus yields best Q1 profitability in company history 2026 is the first year in which we fully focus on the Azerion advertising platform after discontinuing our Premium Games segment in 2025. That focus had a very positive effect on our first quarter. Our overall profitability went up, despite divesting from a segment that contributed positively to the group’s bottom line. This is because the projects we deployed in the last years to optimise the advertising platform are paying off.  Results for the continuing operationsQ1 2026Total Revenue of € 117.4 million (+1.6% compared to € 115.5 million in Q1 2025) Adjusted EBITDA of € 9.4 million (+11.9% compared to € 8.4 million in Q1 2025) EBITDA of € 6.7 million (+42.6% compared to € 4.7 million in Q1 2025) Operating Profit: €(2.0) million (+67.7% compared to € (6.2) million...

Continue reading

Aegon announces agreement with Vereniging Aegon and publishes proposal for US-aligned governance framework

Schiphol, May 28, 2026 – Aegon today announces an agreement with its largest shareholder, Vereniging Aegon, on the future relationship with the Vereniging, alongside a proposed governance framework that will be put in place in connection with Aegon’s planned relocation to the US. Together, these steps are designed to align Aegon’s governance with US market standards and support the company’s ambition to become a leading US life insurance and retirement group. Proposed governance framework Aegon intends to move its legal seat to Delaware, the state of incorporation of the majority of US public companies. In connection with this, Aegon will amend its bye-laws to align Aegon’s governance with US market standards. Key proposed changes include:phased removal of Aegon’s staggered board structure with annual elections for all directors...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.